Effect of prehospital triage on revascularization times, left ventricular function, and survival in patients with

Gopal Sivagangabalan1, Andrew T L Ong, Arun Narayan

  • 1Cardiology Department, Westmead Hospital, Westmead, NSW, Australia.

Insights

Prehospital triage for ST-elevation myocardial infarction (STEMI) significantly reduces door-to-balloon times, improving left ventricular function and early survival. Faster reperfusion is crucial for better patient outcomes.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • Timely reperfusion is critical for improving outcomes in ST-elevation myocardial infarction (STEMI).
  • Current triage protocols may delay treatment, impacting patient prognosis.

Purpose of the Study:

  • To evaluate the effectiveness of prehospital triage with bypass of community hospitals and early cardiac catheterization team activation.
  • To assess the impact on revascularization times, left ventricular ejection fraction, and survival rates in STEMI patients.

Main Methods:

  • A comparative study involving 624 STEMI patients divided into three triage groups: ambulance field triage, interventional center emergency department, and community hospital emergency departments.
  • Analysis of door-to-balloon times, left ventricular ejection fraction, 30-day mortality, and long-term survival up to 30 months.

Main Results:

  • Ambulance field triage significantly decreased median door-to-balloon times by 68 minutes compared to community hospitals and 27 minutes compared to interventional centers.
  • The field triage group showed the highest left ventricular ejection fraction (52%) and the lowest 30-day mortality (3%).
  • Significant differences in long-term survival were observed, with each extra minute from symptom onset to reperfusion associated with increased mortality risk.

Conclusions:

  • Prehospital field triage for STEMI patients reduces revascularization times.
  • This approach preserves left ventricular function and improves early survival rates.
  • Optimizing STEMI patient triage pathways is essential for better clinical outcomes.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...